Phase II study with a new alkylating agent (PTT-119) in lymphoid malignancies.
Tura S, Mazza P, Gherlinzoni F, Zinzani PL, Poletti G, Visani G, Lemoli RM, Bandini G, Cavo M, Galieni P, et al.
Tura S, et al. Among authors: gherlinzoni f.
Haematologica. 1988 Nov-Dec;73(6):503-8.
Haematologica. 1988.
PMID: 3148513
No abstract available.